Compounds > cephalosporin c
Page last updated: 2024-08-24

cephalosporin c and Communicable Diseases, Emerging

cephalosporin c has been researched along with Communicable Diseases, Emerging in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR1
Chen, C; Huang, L; Jia, L; Jin, H; Keim, P; Li, J; Liu, N; Liu, W; Qiu, S; Song, H; Su, W; Wang, H; Wang, L; Wang, Y; Wang, Z; Xu, X; Yang, G; Yuan, Z; Zhang, L1
Fritsche, TR; Jones, RN; Pfaller, MA; Sader, HS1
Beall, B; Besser, JM; Boxrud, DJ; Gertz, RE; Harrison, LH; Jorgensen, JH; McEllistrem, MC; Whitney, CG1

Other Studies

4 other study(ies) available for cephalosporin c and Communicable Diseases, Emerging

ArticleYear
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States

2010
Emergence of resistance to fluoroquinolones and third-generation cephalosporins in Shigella flexneri subserotype 1c isolates from China.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:4

    Topics: Cephalosporins; China; Communicable Diseases, Emerging; Diarrhea; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Electrophoresis, Gel, Pulsed-Field; Feces; Fluoroquinolones; Genetic Variation; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Nalidixic Acid; Serotyping; Shigella flexneri

2012
Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Diagnostic microbiology and infectious disease, 2006, Volume: 56, Issue:1

    Topics: Anti-Bacterial Agents; Canada; Cefepime; Ceftazidime; Cephalosporins; Communicable Diseases, Emerging; Drug Interactions; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Sentinel Surveillance; United States

2006
Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States.
    The Journal of infectious diseases, 2002, Jul-01, Volume: 186, Issue:1

    Topics: Adolescent; Adult; Alleles; Aminoacyltransferases; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporins; Child; Communicable Diseases, Emerging; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hexosyltransferases; Humans; Microbial Sensitivity Tests; Middle Aged; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumococcal Infections; Streptococcus pneumoniae; United States

2002